Geraldine A. Hamilton, PhD

Geraldine is a world-renowned scientist and entrepreneur dedicated to advancing human health, longevity, and biomedical research through cutting-edge technologies. With over 25 years of experience spanning startups, academia, and the biotech industry, she has consistently operated at the forefront of innovation. ​

At Harvard University, Geraldine built and led the team that developed the revolutionary Organs-on-Chips technology and co-founded Emulate, Inc., where she served as Chief Scientific Officer, President, and board member. Her groundbreaking work has been featured by National Geographic, TED (viewed by millions), BBC, WIRED, Fast Company, Bloomberg, NBC News, The Wall Street Journal, and the Museum of Modern Art.

The Organs-on-Chips technology was named Design of the Year by the London Design Museum and is part of the museum’s permanent collection. Geraldine also holds an extensive portfolio of patents and has been widely published in leading scientific journals. 

Named by Fortune Magazine as one of the top leaders transforming healthcare, Geraldine operates at the nexus of biology, engineering, and design, driving the translation of pioneering technologies into successful startups and impactful products. 

Her influence spans advancing biomedical research and understanding disease mechanisms, drug discovery and development, creating personalized medicine technologies, and shaping the regulatory landscape. She played a pivotal role in the passage of the FDA Modernization Act 2.0, paving the way for alternatives to animal testing in drug development.